EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment

Andrzej Silczuk iD, Robert J Madejek iD, Tytus Koweszko iD, Paulina Mularczyk-Tomczewska iD, Ewelina Adamska, Mariusz Gujski iD, Agata Szulc iD

Medical Science Monitor · 2025

DOI: 10.12659/msm.948302 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Andrzej Silczuk und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Environmental Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland. Hauptthemen laut MEDLINE: Hallucinogens, Psychotherapy, Mental Disorders. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psychedelics, derived from the Greek words "psyche" (soul) and "deloun" (revealing), are substances historically and currently considered "soul-revealing". Also termed hallucinogens due to their impact on sensory perception, they are further categorized into hallucinogens, such as lysergic acid diethylamide (LSD), psilocybin, and mescaline; entactogens or empathogens, such as 3,4-methylenedioxymethamphetamine (MDMA); and dissociatives, such as phencyclidine (PCP) and ketamine. The concept of using these substances to enhance psychotherapy emerged in the 1940s, leading to the first wave of psychedelic research, which yielded promising initial results. Following a period of restricted research, modern investigations began anew around 20 years ago. In this review, we analyze the last 10 years of research, exploring the potential of psychedelics in psychotherapy. Current evidence reveals that psychedelic-assisted psychotherapy remains an experimental approach. While preliminary studies suggest potential therapeutic benefits in treating various conditions, including depression, post-traumatic stress disorder, obsessive-compulsive disorder, and substance use disorders, a definitive assessment of efficacy and safety is hampered by the scarcity of large-scale, rigorous clinical trials. Psychedilics should rather be viewed as integral components of broader therapeutic frameworks than as standalone treatment. The unique mechanisms of psychedelics, notably their effect on neuroplasticity, hint at the potential to address treatment gaps in patients unresponsive to conventional methods. However, this potential requires validation through larger, more rigorously designed studies. Future research must prioritize high-quality, randomized, double-blind, placebo-controlled trials encompassing diverse populations to produce reliable, generalizable findings and ensure responsible clinical implementation. The aim of this article is to review the current status of psychedelic-assisted psychotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensPsychotherapyMental DisordersHumansMental HealthLysergic Acid Diethylamide

Substanzen

HallucinogensLysergic Acid Diethylamide

Autor:innen und Institutionen

  • Department of Environmental Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.
  • Department of Public Health, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.
  • Department of Psychiatry, Faculty of Health Sciences, Medical University of Warsaw, Warsaw, Poland.

ORCID-Profile: Andrzej Silczuk, Robert J Madejek, Tytus Koweszko, Paulina Mularczyk-Tomczewska, Mariusz Gujski, Agata Szulc

Zitieren

APA

Silczuk, A., Madejek, R. J., Koweszko, T., Mularczyk-Tomczewska, P., Adamska, E., Gujski, M., & Szulc, A. (2025). Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment. Medical Science Monitor. https://doi.org/10.12659/msm.948302

Vancouver

Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, et al. Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment. Medical Science Monitor. 2025. doi:10.12659/msm.948302

BibTeX
@article{Silczuk2025,
  author = {Silczuk, Andrzej and Madejek, Robert J and Koweszko, Tytus and Mularczyk-Tomczewska, Paulina and Adamska, Ewelina and Gujski, Mariusz and Szulc, Agata},
  title = {Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.948302}
}
Kostenlos starten →